Loading...
Market
AI-created treatment approved by major health regulatory body by end of 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Approval announcements from health regulatory bodies like the FDA or EMA
Story
AI Creates Experimental Treatment for Neglected Disease, Aiming to Democratize Drug Discovery by David Baker's Team
Jan 16, 2025, 12:08 PM
Researchers have developed an experimental treatment for a neglected disease using artificial intelligence, marking a significant advancement in drug discovery. The project, led by Nobel laureate David Baker and researcher Susana Vaz Torres, aims to 'democratize' the development of therapies that have been largely ignored by major pharmaceutical companies. This breakthrough was achieved through the application of AI technologies in the discovery process, showcasing the potential of AI to transform healthcare and address unmet medical needs.
View original story
Similar markets
No • 50%
Yes • 50%
Other • 25%
Pfizer • 25%
Merck • 25%
Johnson & Johnson • 25%
Cancer treatment • 25%
Autoimmune diseases • 25%
Viral infections • 25%
Bacterial infections • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
